Etonogestrel implant in postpartum adolescents: Bleeding pattern, efficacy and discontinuation rate

Contraception

Volumn 82, Issue 3, 2010, Pages 256-259

  Guazzelli, Cristina Ap F ^a   De Queiroz, Flaviano Teixeira ^a   Barbieri, Marcia ^a   Torloni, Maria Regina ^a   De Araujo, Fabio Fernando ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescent; Bleeding; Contraceptive; Etonogestrel; Metabolism; Postpartum

Indexed keywords

ETONOGESTREL;

ADOLESCENT; ADOLESCENT PREGNANCY; AMENORRHEA; ARTICLE; CLINICAL TRIAL; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPLANT; NORMAL HUMAN; PREGNANCY; PUERPERIUM; VAGINA BLEEDING;

ADOLESCENT; CHI-SQUARE DISTRIBUTION; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DRUG IMPLANTS; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES;

EID: 77955570518     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.02.010     Document Type: Article

References (16)

1. Paranjothy S., Broughton H., Adappa R., and Fone D. Teenage pregnancy: who suffers? Arch Dis Child 94 3 2009 239 245
2. Coley R.L., and Chase-Lansdale P.L. Adolescent pregnancy and parenthood. Recent evidence and future directions Am Psychol 53 2 1998 152 166
3. Mestad R.E., Kenerson J., and Peipert J.F. Reversible contraception update: the importance of long-acting reversible contraception Postgrad Med 121 4 2009 18 25
4. World Health Organization Medical eligibility criteria for contraceptive use. Reproductive Heath and Research 4th ed 2008 WHO Geneva
5. Hohmann H., and Creinin M.D. The contraceptive implant Clin Obstet Gynecol 50 4 2007 907 917
6. Graesslin O., and Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience Eur J Contracept Reprod Health Care 13 Suppl 1 2008 4 12
7. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of implanon Contraception 58 Suppl 1998 99S 107S
8. Simon C.S., Kelly L., and Singer D. Preventing repeat adolescent pregnancies with early adoption of contraceptive implant Fam Plann Perspect 31 2 1999 88 93
9. Belsey E.M., Machin D., and d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods Contraception 34 1986 253 260
10. World Health Organization Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting Bull WHO 71 6 1993 677 689
11. Rodriguez G., Faundes-Latham A., and Atkinson L.A.N. Approach to analysis of menstrual patterns in the clinical evaluation of contraceptives Stud Fam Plann 7 1976 42 51
12. Altman D. Practical statistics for medical research 1991 Chapman & Hall London 250
13. Harvey C., Seib C., and Lucke J. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia Contraception 80 6 2009 527 532
14. Mansour D., Korver T., Marintcheva-Petrova M., and Fraser I.S. The effects of Implanon on menstrual bleeding patterns Eur J Contracept Reprod Health Care 13 Suppl 1 2008 13 28
15. World Health Organization Effects of contraceptives on hemoglobin and ferritin. Task Force for Epidemiological Research on Reproductive Health, United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction Contraception 58 5 1998 262 273
16. Polaneczky M., Slap G., Forke C., Rappaport B.S., and Sondheimer S. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers N Engl J Med 331 1994 1201 1206